We are live on
!
Find out more
CSI
Cross Staff Investments Portfolio holdings
AUM
$178M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+7.6%
1 Year Est. Return
+21.21%
3 Year Est. Return
+81.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$5.86M
(+5.2%)
Cap. Flow
+$565K
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
37%
Holding
123
New
9
Increased
13
Reduced
32
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIRA Pharmaceuticals
MIRA
|
+$416K |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$275K |
| 3 |
Eaton
ETN
|
+$224K |
| 4 |
Veeva Systems
VEEV
|
+$216K |
| 5 |
Ecolab
ECL
|
+$212K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$460K |
| 2 |
Roku
ROKU
|
+$275K |
| 3 |
Microsoft
MSFT
|
+$236K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$116K |
| 5 |
KKR & Co
KKR
|
+$93.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.26% |
| 2 | Technology | 17.07% |
| 3 | Industrials | 8.97% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Energy | 8.38% |
Similar funds
ACM
NRWA
SMTF
IAMH
ACM
CNWM
AGC
PS
Cross Staff Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Cross Staff Investments held 123 positions worth $119M, up 5.2% from $113M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Cross Staff Investments's Q1 2024 filing shows 9 new, 13 increased, 32 reduced and 2 closed positions. Its largest new stake was MIRA Pharmaceuticals: 383,401 shares worth $422K. The largest sale was Elevance Health, an estimated $460K.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Cross Staff Investments's largest Q1 2024 buy was MIRA Pharmaceuticals: 383,401 shares worth $422K.
- Cross Staff Investments added most to Schwab US Broad Market ETF in Q1 2024, an estimated $275K increase.
- Cross Staff Investments's biggest Q1 2024 reduction was Microsoft, cutting an estimated $236K.
- Cross Staff Investments fully exited Elevance Health in Q1 2024, selling an estimated $460K.
- Cross Staff Investments's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
- Cross Staff Investments opened 9 new positions and closed 2 in Q1 2024.
- Cross Staff Investments's portfolio value rose 5.2% quarter-over-quarter to $119M.
Based on Cross Staff Investments's 13F filing for Q1 2024, filed 1 May 2024.